Content Library
Access past presentations from the NeoAg Event Series!
Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences
Beyond Algorithms: the ATLAS Bioassay Method for Neoantigen Identification and Characterization
Andrew Allen, CEO, Gritstone Oncology
Using Normal Immune Responses as Engine for Cancer Immunotherapy
Gavin MacBeath, Chief Scientific Officer, TScan Therapeutics
A Genome-wide Approach to Discovering Novel Targets and TCRs for T Cell Therapy
Hans-Peter Gerber ,CSO & SVP, 3T Biosciences
Identification of Novel Shared Targets in Solid Tumors
